BCR and B-cell chronic lymphocytic leukemia: IGHV‐mutated CLL (M‐CLL) cells typically exhibit weak BCR signaling and a more anergic phenotype, characterized by reduced surface IgM expression, impaired calcium mobilization, and attenuated downstream signaling cascades.